New S-ketamine therapy for drug-resistant depression treatment
The project is titled: ”New S-ketamine therapy in the treatment of drug-resistant depression”. Its goal is to develop an innovative route of administration of a known anesthetic that has immediate and persistent antidepressant activity confirmed in several clinical trials conducted over the past decade.
Celon Pharma S.A., thanks to its experience, proposes the use of technology that will not only allow patients to use the medicine on their own, but also provide the doctor with control over the applied dose using digital techniques.
Your project description
To add a photo, description, specify a location or attach other materials about the project, you should fill out the form below. After clicking the “send” button, a message will be sent to you e-mail asking for confirmation. You must accept to submit the form. The EU Dot Map Guidelines and consent to the processing of personal data. materials will be sent to the editor of the site, who will publish it on the website after verification test.